Quantcast

Latest Methylphenidate Stories

2010-05-19 08:15:00

PHILADELPHIA, May 19 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, will present scientific data on its Attention Deficit Hyperactivity Disorder (ADHD) treatments Vyvanse® (lisdexamfetamine dimesylate) Capsules CII and INTUNIV(TM) (guanfacine) Extended Release Tablets at two national scientific meetings for psychiatrists May 20-26, 2010 in New Orleans, LA. "We believe that the Vyvanse and INTUNIV study...

2010-05-13 08:39:32

Several barriers prevent minority children with ADHD from receiving the most effective treatments, according to a new study by Michigan State University researchers. In the May issue of the Journal of Attention Disorders, the researchers argue schools and communities should do a better job of getting information to minority families about the combined benefit of medication and counseling for attention deficit hyperactivity disorder. "ADHD has multiple causes and multiple treatment approaches...

2010-05-04 11:48:13

Children with ADHD who carry a specific type of dopamine receptor gene respond better to the drug methylphenidate (MPH) than those without the genotype, according to new research from Cincinnati Children's Hospital Medical Center. The findings come from the first-ever placebo-controlled pharmacogenetic drug trial for Attention Deficit/Hyperactivity Disorder in school age children to evaluate variants of the DRD4 dopamine receptor gene using teacher ratings of children's symptoms. The research...

2010-04-26 13:01:00

MORRISTOWN, N.J., April 26 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that the U.S. Court of Appeals for the Federal Circuit Court has affirmed a March 31, 2009 District Court decision that the asserted claims of ALZA's United States Patent No. 6,919,373 "the '373 Patent" are invalid. The original suit by ALZA Corporation and McNeil-PPC, Inc. alleged that Watson's generic versions of Concerta® (methylphenidate hydrochloride...

2010-04-26 11:56:00

TITUSVILLE, N.J., April 26 /PRNewswire/ -- The Court of Appeals for the Federal Circuit has denied an appeal by McNeil Pediatrics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., to overturn a 2009 decision by the U.S. District Court of Delaware that the patent for CONCERTA (methylphenidate HCl) Extended-Release Tablets CII is invalid and not infringed by Andrx Corporation. In December 2007, McNeil Pediatrics, which markets CONCERTA, and ALZA Corporation, the owner of the...

2010-04-15 13:02:50

Medication and behavioral interventions help children with Attention Deficit Hyperactivity Disorder (ADHD) better maintain attention and self control by normalizing activity in the same brain systems, according to researchers at The University of Nottingham. In a study, funded by the Wellcome Trust and published today in the journal Biological Psychiatry, researchers led by Chris Hollis, Professor of Child and Adolescent Psychiatry, in the School of Community Health Sciences, have shown that...

07cf77f4546e43be76b06de74b58fcf8
2010-03-08 08:41:49

Doctors treat millions of children with Ritalin every year to improve their ability to focus on tasks, but scientists now report that Ritalin also directly enhances the speed of learning. In animal research, the scientists showed for the first time that Ritalin boosts both of these cognitive abilities by increasing the activity of the neurotransmitter dopamine deep inside the brain. Neurotransmitters are the chemical messengers neurons use to communicate with each other. They release the...

2010-02-23 10:09:49

In the final article in a six part series on treating mental health problems in resource-poor settings, Alan Flisher, from the University of Cape Town, and colleagues present "packages of care" for treating Attention-Deficit/Hyperactivity Disorder in low- and middle-income countries. Attention-deficit/hyperactivity disorder (AD/HD) is a pervasive developmental disorder that, although commonest in childhood and adolescence, can be diagnosed at any age. The chronic condition affects individuals...

2009-12-03 08:00:00

PHILADELPHIA, Dec. 3 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®. Shire is taking this action because some Daytrana patches do not meet or in the future may not meet their release liner removal specification, and as a result, patients and...

5356811b4430aba810193467d5fef1cb
2009-12-02 15:29:12

Fruit flies may seem like unlikely heroes in the battle against drug abuse, but new research suggests that these insects "” already used to study dozens of human disease "” could claim that role. Scientists are reporting that fruit flies can be used as a simpler and more convenient animal model for studying the effects of cocaine and other drugs of abuse on the brain. Their study appears online in ACS Chemical Neuroscience, a new monthly journal. Andrew Ewing and colleagues note...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'